Acorda Therapeutics reported $20.46M in Gross Profit on Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
ALKERMES ALKS:US 244.58M 6.01M
Amgen AMGN:US $ 5097M 208M
Anika Therapeutics ANIK:US $ 23.02M 2.21M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Clovis Oncology CLVS:US $ 28.07M 0.88M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Insmed INSM:US $ 36.57M 2.04M
Ligand Pharmaceuticals LGND:US $ 53.39M 0.69M
Mannkind MNKD:US $ 12.32M 1.03M
Merck MRK:GR € 3114M 57M
Moderna Inc MRNA:US 4.25B 643M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Pfizer PFE:US $ 14163M 2178M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M